Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05690282Phase 4Active, not recruiting
Phase 4, randomised, open-label trial of ibuprofen, acetaminophen, gabapentin and bupivacaine in postoperative pain (2 arms), sponsored by University of California, San Diego. Primary endpoint: Morphine equivalents used at 1 year. Started May 2021; status: active, not recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05690282.